ArticleHeliyon2024

Characterization of the in vitro metabolic profile of nazartinib in HLMs using UPLC-MS/MS method: In silico metabolic lability and DEREK structural alerts screening using StarDrop software.

Mohamed W Attwa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.